Atlas Trials

Sildenafil Therapy for Pulmonary Hypertension and Sickle Cell Disease

Clinical trial NCT00492531 · TERMINATED

Trial details

NCT number
NCT00492531
Sponsor
National Heart, Lung, and Blood Institute (NHLBI)
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Sickle Cell DiseasePulmonary Hypertension
Start date
2007-06-01
Primary completion
2009-09-01
Enrollment
74

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.